Kang Chao

7PUBLICATIONS
9CO-AUTHORS
Immunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunityCancer geneticsAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 20, 2025
Risk factors and clinical characteristics of Clostridium difficile colonization and infection in patients with inflammatory bowel disease exposed to Vedolizumab: a multicenter retrospective study.

Qing Li, Xiaomei Song, Peizhu Su

|Dec 22, 2024
Clinical decision support tool-guided, selective intensive induction strategy of ustekinumab in patients with Crohn's disease: A multicenter cohort study.

Qing Li, Jian Tang, Zhao Peng Huang

|Dec 20, 2024
PI(4,5)P2 alleviates colitis by inhibiting intestinal epithelial cell pyroptosis through NNMT-mediated RBP4 m6A modification.

Qingfan Yang, Na Diao, Fei Ma

|Oct 18, 2024
Comparison of clinical and endoscopic efficacy between vedolizumab and infliximab in bio-naïve patients with ulcerative colitis: a multicenter, real-world study.

Zhaopeng Huang, Jian Tang, Ruibin Wu

|Aug 21, 2024
Concordance of phenotypic characteristics among patients with familial Crohn's disease in China.

Xiao Xia Deng, Min Zhi Lin, Xiang Gao

|Jun 26, 2024
Intestinal mRNA expression profiles associated with mucosal healing in ustekinumab-treated Crohn's disease patients: bioinformatics analysis and prospective cohort validation.

Qing Li, Zicheng Huang, Hongsheng Yang

Pageof 2

Frequent Collaborators

5 joint publications

Xiang Gao

2 joint publications

Zhaopeng Huang

2 joint publications

Qin Guo

1 joint publications

Xiao Xia Deng